Trailing-twelve-month (TTM) revenue is $509.02 Million with a year-over-year growth of +7.94%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $125,993,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-10 |
| Q4 FY2025Period ended 2025-12-31 | $128,124,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-18 |
| Q1 FY2026Period ended 2026-03-31 | $121,659,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-12 |
| Q2 FY2026Period ended 2026-06-30 | $133,243,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-10 |
| TTM revenue | $509,019,000 |
Current P/S: $6,903,762,305 market capitalization ÷ $509,019,000 TTM revenue = 13.56x.
Market capitalization source: FMP quote. Quote observed 2026-09-11T20:00:01.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $133.24M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-12T00:15:15.608Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-10.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Sales of products | $148M | $259M | $308M | $302M | $409M | $469M |
| Service fees | $8M | $10M | $13M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Asia Pacific | $138M | $225M | $63M | $68M | $134M | $169M |
| CHINA | N/A | N/A | $142M |
$509.02M
$509.02 Million
+7.94%
vs. $471.58M a year ago (TTM)
+18.98%
5 Year compound annual growth rate
1 Year
+7.94%
3 Year
+17.92%
5 Year
+18.98%
10 Year
+17.23%
15 Year
+11.05%
20 Year
+9.06%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $496.07M | +$66.84M | +15.57% |
| 2024 | $429.23M | +$113.86M | +36.10% |
| 2023 | $315.38M | ($5.53M) | (1.72%) |
| 2022 | $320.91M | +$51.25M | +19.01% |
| 2021 | $269.66M | +$113.80M | +73.01% |
| 2020 |
TTM Growth
+7.94%
3-Year CAGR
+17.92%
5-Year CAGR
+18.98%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-12T00:15:15.608Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-10.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $20M |
| $28M |
| $133M |
| $244M |
| Europe | $8M | N/A | N/A | $10M | $16M | $17M |
|---|
| KOREA, REPUBLIC OF | N/A | N/A | $43M | $47M | $117M | $37M |
|---|
| United States | $10M | $29M | $55M | $41M | $29M | N/A |
|---|
| UNITED STATES | N/A | N/A | N/A | N/A | N/A | $29M |
|---|
| Western Europe | N/A | $16M | $17M | N/A | N/A | N/A |
|---|
| $155.86M |
| +$21.84M |
| +16.30% |
| 2019 | $134.02M | +$10.85M | +8.80% |
| 2018 | $123.17M | +$29.69M | +31.76% |
| 2017 | $93.48M | ($16.04M) | (14.64%) |
| 2016 | $109.52M | +$10.25M | +10.32% |
